Biosergen publicerar delårsrapport för tredje kvartalet 2025
November 19, 2025 | Placera
... 2025 2024 2025 2024 2024 TSEK Jul-Sep Jul-Sep Jan-Sep Jan-Sep Jan-Dec Resultaträkning ...


Biosergen AB: Biosergen publicerar delårsrapport för tredje kvartalet 2025
November 19, 2025 | swedbank-aktiellt
... "Under tredje kvartalet 2025 fokuserade vi på att förbereda nästa fas i utvecklingen a...


Immunobiology Research Institute Hits Limit Up - HIV Antibody Patent Approval Sparks Buying Frenzy
November 19, 2025 | BTCC
Buyers keep buying as positive momentum builds around groundbreaking HIV treatment technol...


Scripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development (IMAGE)
November 19, 2025 | EurekAlert!
Scripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine de...


Scripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
November 18, 2025 | EurekAlert!
New AI system helps scientists rapidly pinpoint the most promising paths to an HIV vaccine...


CU Anschutz telenovela study aims to educate Latinos on HIV management
November 18, 2025 | NewsBreak
DENVER | Kiko has a classic and conservative sense of style that’s reflected in his quaint...


Anxiety responses and testing intentions among gay and bisexual men using an AI-powered HIV/STI risk assessment tool: a quasi-experimental study
November 18, 2025 | Springer
Abstract Introduction Web-based tools for the assessment of the risk of sexually transmi...


A Dual Prevention Pill for HIV & Pregnancy Prevention: A Pilot Study Among Adolescent Girls and Young Women in Zimbabwe
November 18, 2025 | Springer
Abstract Adolescent girls and young women (AGYW) in sub-Saharan Africa are at risk for HI...


More than entertainment, a CU researcher uses telenovelas to support Latinos with HIV
November 18, 2025 | KUNC-FM
KUNC | By Stephanie Daniel Published November 18, 2025 at 6:00 AM MST Facebook Twitter ...


Gilead Joins Partners for Delivery of First Shipments of Breakthrough Twice-yearly Lenacapavir for HIV Prevention to Sub-Saharan Africa
November 18, 2025 | Placera
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the delivery of first shipments of le...